Osteoporosis in multiple sclerosis patients:: dependence on corticosteroid therapy and motor deficit

被引:0
作者
Havrdová, E
Tyblová, M
Stepan, J
Horáková, D
Tichá, V
Nováková, I
Zelená, L
Zikán, V
Hlásenska, J
机构
[1] VFN, LF UK, Neurol Klin 1, Prague 12808 2, Czech Republic
[2] VFN, LF UK, Interni Klin 1 3, Prague 12808 2, Czech Republic
[3] AV CR, Ustav Informat, Prague, Czech Republic
关键词
multiple sclerosis; osteoporosis; glucocorticoids; immobility; D vitamin; calcium;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction. Treatment of multiple sclerosis (MS) cannot presently avoid repeated administration of high doses of corticosteroids. One of the most feared and best documented adverse effects is steroid-induced osteoporosis. The goal of our study was to find the relationship of the decrease in bone density to the administered cumulative dose of steroids and to other risk factors in MS, primarily to the degree of motor deficit. We have also investigated, to what degree the patients are provided with preventive measures against osteoporosis. Patients and methods. Densitometry was performed in 591 patients with MS (455 women, 136 men, age. 42.8 plus or minus 10.3 years, MS duration 12.1 plus or minus 7.7 years) in different stages of the disease (42.3 % in remitting stage, 49.8 % in secondary progression, 7.9 % in primary progression) with a various degree of motor deficit (Kurtzke EDSS of the whole group was 4.3 plus or minus 1.8). Results: Osteoporosis as defined by WHO (T-score lower than -2.5) was detected in 26.4 % of patients. Correlation with the total received dose of steroids was significant but not very high whereas correlation with the degree of immobility was very high (P < 0.001). Number of osteoporotic fractures was also more dependent on immobility than on the amount of administered steroids, furthermore, 56 % of fractures occurred in post-menopausal women. We have also found other risk factors: low calcium intake, low body mass index and high consumption of alcohol. 94 % of patients at the time of the first densitometry had been using no preventive measures against steroid-induced osteoporosis, that is, the recommended dose of D vitamin and calcium from the beginning of corticosteroid treatment. Conclusion. Osteoporosis is a significant co-morbidity of MS, primarily due to a combination of motor deficit, steroid treatment and menopause in women. Timely introduction of preventive measures according to international recommendations is necessary.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 1996, Arthritis Rheum, V39, P1791
[2]  
Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496
[3]  
COSMAN F, 1994, J BONE MINER RES, V9, P1097
[4]   A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update [J].
Eastell, R ;
Reid, DM ;
Compston, J ;
Cooper, C ;
Fogelman, I ;
Francis, RM ;
Hosking, DJ ;
Purdie, DW ;
Ralston, SH ;
Reeve, J ;
Russell, RGG ;
Stevenson, JC ;
Torgerson, DJ .
JOURNAL OF INTERNAL MEDICINE, 1998, 244 (04) :271-292
[5]   Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria [J].
Edan, G ;
Miller, D ;
Clanet, M ;
Confavreux, C ;
LyonCaen, O ;
Lubetzki, C ;
Brochet, B ;
Berry, I ;
Rolland, Y ;
Froment, JC ;
Dousset, V ;
Cabanis, E ;
IbaZizen, MT ;
Gandon, JM ;
Lai, HM ;
Moseley, I ;
Sabouraud, O .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (02) :112-118
[6]   Vitamin D: A millenium perspective [J].
Holick, MF .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) :296-307
[7]  
Holick MF, 2003, RECENT RESULTS CANC, V164, P3
[8]   Prevalence of reduced bone mass in children and adults with spastic quadriplegia [J].
King, W ;
Levin, R ;
Schmidt, R ;
Oestreich, A ;
Heubi, JE .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2003, 45 (01) :12-16
[9]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[10]  
LEEDS EM, 1990, ARCH PHYS MED REHAB, V71, P207